Evidence map›Paper›PMID 32634445›Full record

ArticleVirus research2020

Pyruvate affects inflammatory responses of macrophages during influenza A virus infection.

Hazar Abusalamah, Jessica M Reel, Christopher R Lupfer

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Virus research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04824365 phase2 / phase3completednot on this mapstarted 2021, after this paper: background citation

Two Week Sub-chronic Double-blinded Placebo Controlled Trial Designed to Determine if Sodium Pyruvate Nasal Spray Will Reduce the Symptoms, Duration and Replication of COVID-19 Infection

TypeinterventionalSponsorCellular Sciences, inc.Ran2021 to 2022Enrolled30ConditionsCOVID-19ArmsSodium Pyruvate, Saline
NCT04871815 phase2 / phase3completednot on this mapstarted 2021, after this paper: background citation

Preliminary Examination of the Effects of Sodium Pyruvate Nasal Spray (N115) on Symptoms Associated With COVID19 Long Haulers.

TypeinterventionalSponsorCellular Sciences, inc.Ran2021 to 2022Enrolled22ConditionsLong COVIDArmssodium pyruvate nasal spray
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Hazar AbusalamahDepartment of Biology, Missouri State University, 901 S. National Ave. Springfield, MO, 65897, USA.
Jessica M ReelDepartment of Biology, Missouri State University, 901 S. National Ave. Springfield, MO, 65897, USA.
Christopher R LupferDepartment of Biology, Missouri State University, 901 S. National Ave. Springfield, MO, 65897, USA. Electronic address: ChristopherLupfer@missouristate.edua.
Missouri State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pyruvate is the end product of glycolysis and transported into the mitochondria for use in the tricarboxylic acid (TCA) cycle. It is also a common additive in cell culture media. We discovered that inclusion of sodium pyruvate in culture media during infection of mouse bone marrow derived macrophages with influenza A virus impaired cytokine production (IL-6, IL-1β, and TNF-α). Sodium pyruvate did not inhibit viral RNA replication. Instead, the addition of sodium pyruvate alters cellular metabolism and diminished mitochondrial reactive oxygen species (ROS) production and lowered immune signaling. Overall, sodium pyruvate affects the immune response produced by macrophages but does not inhibit virus replication.

Indexed as

AnimalsAnti-Inflammatory AgentsCells, CulturedCulture MediaGene ExpressionImmunity, InnateInflammasomesInflammationInfluenza A virusMacrophagesMiceMice, Inbred C57BLPyruvic AcidVirus ReplicationAnti-Inflammatory AgentsCulture MediaInflammasomesPyruvic AcidAntioxidantInflammasomeInflammationInfluenza A virusPyruvate

Identifiers

PMID32634445
PMCPMC7345311
OpenAlexW3039282338

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.